A network pharmacology-based investigation of emodin against pancreatic adenocarcinoma

Pancreatic adenocarcinoma (PAAD) is one of the most common malignancies worldwide with an increasing incidence and poor outcome due to the lack of effective diagnostic and treatment methods. Emerging evidence implicates that emodin displays extensive spectrum anticancer properties. Differential expression genes in PAAD patients were analyzed by Gene Expression Profiling Interactive Analysis (GEPIA) website, and the targets of emodin were obtained via Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. Subsequently, enrichment analyses were performed using R software. A protein–protein interaction (PPI) network was constructed by STRING database and Cytoscape software was used to identify the hub genes. Prognostic value and immune infiltration landscapes were explored through Kaplan–Meier plotter (KM plotter) website and the Single-Sample Gene Set Enrichment Analysis package of R. Finally, molecular docking was used to computationally verify the interaction of ligand and receptor proteins. A total of 9191 genes were significantly differentially expressed in PAAD patients and 34 potential targets of emodin were obtained. Intersections of the 2 groups were considered as potential targets of emodin against PAAD. Functional enrichment analyses illustrated that these potential targets were linked to numerous pathological processes. Hub genes identified through PPI networks were correlated with poor prognosis and infiltration level of different immune cells in PAAD patients. Perhaps emodin interacted with the key molecules and regulate the activity of them. We revealed the inherent mechanism of emodin against PAAD with the aid of network pharmacology, which provided reliable evidence and a novel guideline for clinical treatment.

[1]  Hu-dan Pan,et al.  Emodin induces apoptosis and suppresses non-small-cell lung cancer growth via downregulation of sPLA2-IIa. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[2]  G. Krijger,et al.  Targeting of promising transmembrane proteins for diagnosis and treatment of pancreatic ductal adenocarcinoma , 2021, Theranostics.

[3]  A. Viljoen,et al.  Emodin - A natural anthraquinone derivative with diverse pharmacological activities. , 2021, Phytochemistry.

[4]  S. Shukla,et al.  Oxygen gradient and tumor heterogeneity: The chronicle of a toxic relationship. , 2021, Biochimica et biophysica acta. Reviews on cancer.

[5]  S. Gaffen,et al.  The metabolism-modulating activity of IL-17 signaling in health and disease , 2021, The Journal of experimental medicine.

[6]  Jongdae Lee,et al.  The Multifaceted Role of Th1, Th9, and Th17 Cells in Immune Checkpoint Inhibition Therapy , 2021, Frontiers in Immunology.

[7]  Joshua J. Breunig,et al.  A Transcriptional Regulatory Loop of Master Regulator Transcription Factors, PPARG, and Fatty Acid Synthesis Promotes Esophageal Adenocarcinoma , 2021, Cancer Research.

[8]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[9]  Juanni Li,et al.  Spectrum of Mesenchymal–Epithelial Transition Aberrations and Potential Clinical Implications: Insights From Integrative Pancancer Analysis , 2020, Frontiers in Oncology.

[10]  P. Paoli,et al.  Role of tyrosine phosphorylation in modulating cancer cell metabolism. , 2020, Biochimica et biophysica acta. Reviews on cancer.

[11]  L. De Monte,et al.  Thymic Stromal Lymphopoietin and Cancer: Th2-Dependent and -Independent Mechanisms , 2020, Frontiers in Immunology.

[12]  Charles R. Thomas,et al.  Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma , 2020, CA: a cancer journal for clinicians.

[13]  Qing Liu,et al.  Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation , 2020, Theranostics.

[14]  Longlong Wang,et al.  Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription , 2020, Theranostics.

[15]  C. Verschoor,et al.  Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer , 2020, Frontiers in Immunology.

[16]  E. Snell,et al.  Structural insights into conformational switching in latency-associated peptide between transforming growth factor β-1 bound and unbound states , 2020, IUCrJ.

[17]  Jie Pan,et al.  Demethylation and Overexpression of CSF2 are Involved in Immune Response, Chemotherapy Resistance, and Poor Prognosis in Colorectal Cancer , 2019, OncoTargets and therapy.

[18]  H. Crawford,et al.  Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice. , 2019, Gastroenterology.

[19]  F. Végran,et al.  Cleaved Caspase-3 transcriptionally regulates angiogenesis promoting chemotherapy resistance. , 2019, Cancer research.

[20]  I. Holen,et al.  Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment , 2019, Clinical Cancer Research.

[21]  M. Najafi,et al.  Cyclooxygenase‐2 in cancer: A review , 2018, Journal of cellular physiology.

[22]  E. Unger,et al.  Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment , 2018, International journal of nanomedicine.

[23]  Chuan-Yuan Li,et al.  Caspase‐3 regulates the migration, invasion and metastasis of colon cancer cells , 2018, International journal of cancer.

[24]  A. Maitra,et al.  Immune Cell Production of Interleukin 17 Induces Stem Cell Features of Pancreatic Intraepithelial Neoplasia Cells. , 2018, Gastroenterology.

[25]  P. Griffin,et al.  PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix , 2018, iScience.

[26]  D. Elston,et al.  When worlds collide: Th17 and Treg cells in cancer and autoimmunity , 2018, Cellular & Molecular Immunology.

[27]  A. Culyer.  Spearman Rank Correlation Coefficient , 2007 .

[28]  R. Vij,et al.  CD56bright NK cells exhibit potent antitumor responses following IL-15 priming , 2017, The Journal of clinical investigation.

[29]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[30]  J. Meephansan,et al.  Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis , 2016, International journal of molecular sciences.

[31]  Yuzhen Wang,et al.  Emodin Inhibits Breast Cancer Growth by Blocking the Tumor-Promoting Feedforward Loop between Cancer Cells and Macrophages , 2016, Molecular Cancer Therapeutics.

[32]  M. Malkowski,et al.  Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry. , 2016, Biochemistry.

[33]  N. Carragher,et al.  FLT1 signaling in metastasis-associated macrophages activates an inflammatory signature that promotes breast cancer metastasis , 2015, The Journal of experimental medicine.

[34]  Chung-Yen Lin,et al.  cytoHubba: identifying hub objects and sub-networks from complex interactome , 2014, BMC Systems Biology.

[35]  Wei Zhou,et al.  TCMSP: a database of systems pharmacology for drug discovery from herbal medicines , 2014, Journal of Cheminformatics.

[36]  Tao Xi,et al.  Emodin-provoked oxidative stress induces apoptosis in human colon cancer HCT116 cells through a p53-mitochondrial apoptotic pathway. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[37]  G. Sethi,et al.  Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer. , 2013, Cancer letters.

[38]  Z. Trajanoski,et al.  Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. , 2013, Immunity.

[39]  L. Yanqin,et al.  Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway , 2013, Cancer Cell International.

[40]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[41]  Chi V. Dang,et al.  Otto Warburg's contributions to current concepts of cancer metabolism , 2011, Nature Reviews Cancer.

[42]  Karen N. Allen,et al.  Engineering encodable lanthanide-binding tags into loop regions of proteins. , 2011, Journal of the American Chemical Society.

[43]  M. Kahn,et al.  Kinetic and structural characterization of caspase-3 and caspase-8 inhibition by a novel class of irreversible inhibitors. , 2010, Biochimica et biophysica acta.

[44]  M. Wei,et al.  A new dawn for the use of traditional Chinese medicine in cancer therapy , 2009, Molecular Cancer.

[45]  P. A. Harris,et al.  Discovery of novel benzimidazoles as potent inhibitors of TIE-2 and VEGFR-2 tyrosine kinase receptors. , 2007, Journal of medicinal chemistry.

[46]  B. Evers,et al.  Upregulation and redistribution of integrin α6β4 expression occurs at an early stage in pancreatic adenocarcinoma progression , 2007, Modern Pathology.

[47]  T. Mok,et al.  KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer , 2007, Journal of Cancer Research and Clinical Oncology.

[48]  K. Acharya,et al.  Crystal Structure of an Active Form of Human MMP-1 , 2006, Journal of molecular biology.

[49]  Jing-Yuan Fang,et al.  The MAPK signalling pathways and colorectal cancer. , 2005, The Lancet. Oncology.

[50]  R. Wolff,et al.  Pancreatic cancer , 2004, The Lancet.

[51]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[52]  Gary D. Bader,et al.  An automated method for finding molecular complexes in large protein interaction networks , 2003, BMC Bioinformatics.

[53]  C. Janson,et al.  Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. , 2002, Acta crystallographica. Section D, Biological crystallography.

[54]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[55]  K. Diederichs,et al.  Refined crystal structure and mutagenesis of human granulocyte‐macrophage colony‐stimulating factor , 1996, Proteins.